ThyTech presents its cell therapy at the 8th Treg-Directed Therapies Summit 2026 in Boston
Dr. Rafael Correa-Rocha, CSO of ThyTech, participated for the second consecutive year as an invited speaker at the 8th Treg-Directed Therapies Summit 2026 in Boston, where he presented clinical advances of the thyTregs™ cell therapy, featured as one of the event’s highlighted sessions. ThyTech showcased favorable results in pediatric heart transplant patients and progress in […]
The Spanish project ThyTech is presented at the 8th Treg-Directed Therapies Summit 2026 in Boston
Dr. Rafael Correa-Rocha, founder and Chief Scientific Officer (CSO) of ThyTech and researcher at the Gregorio Marañón Health Research Institute (Madrid, Spain), has participated for the second consecutive year as an invited speaker at the 8th Treg-Directed Therapies Summit 2026, which has just concluded in Boston. He delivered the presentation “Uncovering Clinical Advances with thyTregs™ […]
